Globus Medical to Participate in North American Spine Society Annual Meeting

Unveiling Excelsius3D™ Intelligent Imaging System

Audubon, Pennsylvania, UNITED STATES

AUDUBON, Pa., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced it will participate in the 36th Annual Meeting of the North American Spine Society (NASS) being held September 29 through October 2, 2021 at the Boston Convention and Exhibition Center.

Globus Medical will present the latest evolutions in robotic spine and minimally invasive lateral lumbar surgery and showcase the expansion of their spinal implant portfolio with ExcelsiusTM Lateral 360. The recently launched procedural solution leverages leading robotic navigation and implant technologies to transform staged procedures into a single-position lateral surgery. Globus will also unveil the most recent addition to the ExcelsiusTM technology platform—Excelsius3DTM, an intelligent intraoperative 3-in-1 imaging system recently 510(k)-cleared by the Food and Drug Administration. Excelsius3DTM pushes enabling technologies into the future by consolidating cone-beam CT, fluoroscopy, and digital radiography into a single imaging platform.

“As leaders in the musculoskeletal device industry, we are committed to supporting the research, education, and development of medical advancements in spine surgery,” said President and Chief Executive Officer, Dave Demski. “We are proud to partner with NASS and are excited to showcase the applications and clinical experience with our most recent product innovations.”

Globus welcomes NASS attendees to visit Booth #1814 for demonstrations with product experts and to view in-booth presentations below:

Wednesday, September 29th, 10-10:30 AM
Advanced Lateral Procedures: Single Position Lateral and Prone Lateral
Jason D. Zook, MD FAAOS
EmergeOrtho, Morganton, NC

Thursday, September 30th, 9:30-10 AM
The Evolution of Robotics Featuring ExcelsiusGPS®
Jeffrey Goldstein, MD
NYU Langone Seaport Orthopedics Associates, New York, NY

Learn more about the latest procedural solution at

About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at

Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, health epidemics, pandemics and similar outbreaks, including the COVID-19 pandemic, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to comply with laws and regulations that are or may become applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.

Brian Kearns
Senior Vice President, Business Development and Investor Relations
Phone: (610) 930-1800